164 related articles for article (PubMed ID: 2289048)
21. Caco-2 cells in culture synthesize and degrade dopamine and 5-hydroxytryptamine: a comparison with rat jejunal epithelial cells.
Vieira-Coelho MA; Teixeira VL; Guimarães JT; Serrão MP; Soares-da-Silva P
Life Sci; 1999; 64(1):69-81. PubMed ID: 10027744
[TBL] [Abstract][Full Text] [Related]
22. Rat liver and kidney catechol-O-methyltransferase activity measured by high-performance liquid chromatography with fluorescence detection.
Tsunoda M; Takezawa K; Masuda M; Imai K
Biomed Chromatogr; 2002 Dec; 16(8):536-41. PubMed ID: 12474218
[TBL] [Abstract][Full Text] [Related]
23. Catechol-O-methyltransferase and Parkinson's disease.
Reches A; Fahn S
Adv Neurol; 1984; 40():171-9. PubMed ID: 6695593
[TBL] [Abstract][Full Text] [Related]
24. Functional effect of adeno-associated virus mediated gene transfer of aromatic L-amino acid decarboxylase into the striatum of 6-OHDA-lesioned rats.
Sánchez-Pernaute R; Harvey-White J; Cunningham J; Bankiewicz KS
Mol Ther; 2001 Oct; 4(4):324-30. PubMed ID: 11592835
[TBL] [Abstract][Full Text] [Related]
25. Barrier mechanisms for neutrotransmitter monoamines in the choroid plexus.
Lindvall M; Hardebo JE; Owman C
Acta Physiol Scand; 1980 Mar; 108(3):215-21. PubMed ID: 6103637
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of human erythrocyte and gastroduodenal catechol-O-methyltransferase activity by nitecapone.
Schultz E; Tarpila S; Bäckström AC; Gordin A; Nissinen E; Pohto P
Eur J Clin Pharmacol; 1991; 40(6):577-80. PubMed ID: 1884738
[TBL] [Abstract][Full Text] [Related]
27. Importance of membrane-bound catechol-O-methyltransferase in L-DOPA metabolism: a pharmacokinetic study in two types of Comt gene modified mice.
Käenmäki M; Tammimäki A; Garcia-Horsman JA; Myöhänen T; Schendzielorz N; Karayiorgou M; Gogos JA; Männistö PT
Br J Pharmacol; 2009 Dec; 158(8):1884-94. PubMed ID: 19930170
[TBL] [Abstract][Full Text] [Related]
28. Effect of pyridoxal phosphate deficiency on aromatic L-amino acid decarboxylase activity with L-DOPA and L-5-hydroxytryptophan as substrates in rats.
Rahman MK; Nagatsu T; Sakurai T; Hori S; Abe M; Matsuda M
Jpn J Pharmacol; 1982 Oct; 32(5):803-11. PubMed ID: 6983619
[TBL] [Abstract][Full Text] [Related]
29. Activities of aromatic L-amino acid decarboxylase with L-dopa as substrate in brush-border- and basolateral membranes and cytoplasm obtained from rat renal cortex.
Yamazaki N; Sudo J
Jpn J Pharmacol; 1988 Feb; 46(2):193-6. PubMed ID: 3379830
[TBL] [Abstract][Full Text] [Related]
30. Salvianolic acid B as a substrate and weak catechol-O-methyltransferase inhibitor in rats.
Qi Q; Cao L; Li F; Wang H; Liu H; Hao H; Hao K
Xenobiotica; 2015; 45(9):820-7. PubMed ID: 25869243
[TBL] [Abstract][Full Text] [Related]
31. Benserazide decreases central AADC activity, extracellular dopamine levels and levodopa decarboxylation in striatum of the rat.
Jonkers N; Sarre S; Ebinger G; Michotte Y
J Neural Transm (Vienna); 2001; 108(5):559-70. PubMed ID: 11459076
[TBL] [Abstract][Full Text] [Related]
32. Simultaneous determination of 5-hydroxytryptophan and 3-O-methyldopa in dried blood spot by UPLC-MS/MS: A useful tool for the diagnosis of L-amino acid decarboxylase deficiency.
Di Carlo E; Santagata S; Sauro L; Tolve M; Manti F; Leuzzi V; Angeloni A; Carducci C
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Nov; 1185():122999. PubMed ID: 34715572
[TBL] [Abstract][Full Text] [Related]
33. Central action of benserazide after COMT inhibition demonstrated in vivo by PET.
Tedroff J; Hartvig P; Bjurling P; Andersson Y; Antoni G; Långström B
J Neural Transm Gen Sect; 1991; 85(1):11-7. PubMed ID: 1867835
[TBL] [Abstract][Full Text] [Related]
34. Substrate stereospecificity and selectivity of catechol-O-methyltransferase for DOPA, DOPA derivatives and alpha-substituted catecholamines.
Gordonsmith RH; Raxworthy MJ; Gulliver PA
Biochem Pharmacol; 1982 Feb; 31(3):433-7. PubMed ID: 6803810
[TBL] [Abstract][Full Text] [Related]
35. Methoxytyrosine formation as an indicator of catechol-O-methyltransferase activity in rat liver in vivo.
Kehr W; Zimmermann R; Thiede M
Naunyn Schmiedebergs Arch Pharmacol; 1977 Oct; 300(1):19-23. PubMed ID: 593428
[TBL] [Abstract][Full Text] [Related]
36. Characterization of SafC, a catechol 4-O-methyltransferase involved in saframycin biosynthesis.
Nelson JT; Lee J; Sims JW; Schmidt EW
Appl Environ Microbiol; 2007 Jun; 73(11):3575-80. PubMed ID: 17449703
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of catechol-O-methyltransferase activity by two novel disubstituted catechols in the rat.
Nissinen E; Lindén IB; Schultz E; Kaakkola S; Männistö PT; Pohto P
Eur J Pharmacol; 1988 Aug; 153(2-3):263-9. PubMed ID: 3181288
[TBL] [Abstract][Full Text] [Related]
38. Clinical Metabolomics to Segregate Aromatic Amino Acid Decarboxylase Deficiency From Drug-Induced Metabolite Elevations.
Pappan KL; Kennedy AD; Magoulas PL; Hanchard NA; Sun Q; Elsea SH
Pediatr Neurol; 2017 Oct; 75():66-72. PubMed ID: 28823629
[TBL] [Abstract][Full Text] [Related]
39. Effects of the inhibition of aromatic aminoacids decarboxylase on prolactin secretion in humans.
Masturzo P; Murialdo G; Carolei A; Polleri A
Boll Soc Ital Biol Sper; 1979 Feb; 55(4):366-72. PubMed ID: 552852
[TBL] [Abstract][Full Text] [Related]
40. The O-methylated derivative of L-DOPA, 3-O-methyl-L-DOPA, fails to inhibit neuronal and non-neuronal aromatic L-amino acid decarboxylase.
Soares-da-Silva P; Parada A; Serrão P
Brain Res; 2000 Apr; 863(1-2):293-7. PubMed ID: 10773222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
